Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. ARS Other Annual Report to Security Holders
  2. DEFA14A Proxy Proxy Materials
  3. PRER14A Other PRER14A
  4. EFFECT Other Notice of Effectiveness
  5. EFFECT Other Notice of Effectiveness
  6. EFFECT Other Notice of Effectiveness
  7. EFFECT Other Notice of Effectiveness
  8. POS AM Other Post-effective Amendment for Registration Statement
  9. POS AM Other Post-effective Amendment for Registration Statement
  10. POS AM Other Post-effective Amendment for Registration Statement
  11. POS AM Other Post-effective Amendment for Registration Statement
  12. EFFECT Other Notice of Effectiveness
  13. DRS Other Draft Registration Statement
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. ARS Other Annual Report to Security Holders
  16. DEFA14A Proxy Proxy Materials
  17. EFFECT Other Notice of Effectiveness
  18. EFFECT Other Notice of Effectiveness
  19. EFFECT Other Notice of Effectiveness
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 1 of 13 · 258 filings